Bigul

Aether Industries Ltd - 543534 - Intimation For Grant Of Stock Options Under 'Aether Industries Limited Employee Stock Option Scheme 2021'

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Nomination and Remuneration Committee of the Company on November 20, 2022 has approved the grant of 42,716 Stock Options, having Face Value of Rs. 10 each pursuant to 'Aether Industries Limited Employee Stock Option Scheme 2021' (herein referred as AIL ESOS 2021) to eligible employees, upon exercise of Options, as annexed.
20-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Nomination and Remuneration Committee of the Company on November 20, 2022 has approved the issue and allotment of 28,048 Equity Shares of Face Value of Rs. 10 each at exercise price of Rs. 321/- each pursuant to 'Aether Industries Limited Employee Stock Option Scheme 2021' (herein referred as AIL ESOS 2021) to eligible employees upon exercise of Options, as annexed.
20-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Transcript of the Earning Conference Call scheduled on Monday, November 14, 2022, on the financial performance of the Company for the Second Quarter ended on September 30, 2022 is enclosed herewith.
17-11-2022
Bigul

Aether Industries Ltd - 543534 - Audio Recording Of The Earning Conference Call For The Financial Results Of The Second Quarter Ended On September 30, 2022

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the audio recording of the Earning Conference Call for the Financial Results of the Second Quarter ended on September 30, 2022, scheduled on November 14, 2022 is uploaded on the website of the Company, as attached.
14-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In accordance with Regulation 30 and Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the newspaper advertisement published in 'Gujarat Mitra' and 'Financial Express' for the standalone and consolidated unaudited Financial Results for the Second Quarter ended on September 30, 2022, along with the Press Release are enclosed herewith.
12-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

In accordance with Regulation 32(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Monitoring Agency Report for the Second Quarter ended on September 30, 2022, issued by M/s. HDFC Bank Limited is enclosed herewith.
12-11-2022
Bigul

Q2FY23 Quarterly Result Announced for Aether Industries Ltd.

Specialty chemicals company Aether Industries announced Q2FY23 results: The company has recorded a total revenue of Rs 1,466 million in Q2FY23, leading to total revenue of Rs 3,127 million in the H1FY23, which has led to an increase of 6% in the total revenue YoY. The EBITDA remained almost flat YoY from Rs 912 million in H1FY22 to Rs 918 million in H1FY23, thereby resulting in EBITDA margin of 29.4% in H1FY23. PAT increased from Rs 575 million in H1FY22 to Rs 578 million in H1FY23, being almost flat. Revenue for Q2FY23 grew by 1.5% YoY (compared to Q2FY22) from Rs 1,445 million to Rs 1,466 million, but showed a drop by 11.8% compared to Q1FY23, which was envisaged and well-informed by the company in the last quarter also, due to the slowdown in the Pharmaceutical Industry. The company earned an EBITDA of Rs 433 million in Q2FY23 which was down by 0.8% (compared to Q2FY22) and down by 10.9% (compared to Q1FY23). The PAT for the company has been Rs 272 million in Q2FY23 which has increased by 8.0% (compared to Q2FY22) and reduced by 11.1% which is in line with the drop of the revenues (compared to Q1FY23). Commenting on the results, Dr. Aman Desai, Promoter & Whole-time Director, Aether Industries, said, ‘Despite global softening of the overall chemical industry especially the pharmaceutical industry, our company has posted a reasonable quarterly result. As the downward trends stabilise and especially as India continues to be on the forefront of the global CRAMS opportunities, we are significantly optimistic in our overall outlook. We are adding major global customers to our CRAMS list and renewing significant annual contracts. The newly expanded R&D; Centre and pilot plant has been officially inaugurated and is already filling up with new projects across all business models. The Large-Scale Manufacturing business model, despite 2 slow quarters, should soon trend upwards owing to the 5 new products being launched in our upcoming green-field manufacturing site, which is on schedule and on track to stepwise launch by December 2022.” Result PDF
11-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Investor Presentation

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the presentation on Financial Results for the Second Quarter ended on September 30, 2022 is enclosed herewith.
11-11-2022
Bigul

Aether Industries Ltd - 543534 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Press Release on the Financial Results for the Second Quarter ended on September 30, 2022 is enclosed herewith.
11-11-2022
Bigul

Aether Industries Ltd - 543534 - Unaudited Standalone And Consolidated Financial Results For The Second Quarter Ended On September 30, 2022 Along With The Limited Review Report

The unaudited standalone and consolidated financial results for the Second Quarter ended on September 30, 2022 along with the Limited Review Report are attached herewith.
11-11-2022
Next Page
Close

Let's Open Free Demat Account